Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026918
Filing Date
2017-05-12
Accepted
2017-05-12 16:31:28
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v466221_10q.htm 10-Q 327306
2 EXHIBIT 31.1 v466221_ex31-1.htm EX-31.1 7262
3 EXHIBIT 31.2 v466221_ex31-2.htm EX-31.2 7308
4 EXHIBIT 32.1 v466221_ex32-1.htm EX-32.1 4854
5 EXHIBIT 32.2 v466221_ex32-2.htm EX-32.2 4987
12 GRAPHIC logo.jpg GRAPHIC 4335
  Complete submission text file 0001144204-17-026918.txt   3368312

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mbrx-20170331.xml EX-101.INS 675363
7 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20170331.xsd EX-101.SCH 41365
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20170331_cal.xml EX-101.CAL 21664
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20170331_def.xml EX-101.DEF 245229
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20170331_lab.xml EX-101.LAB 299753
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20170331_pre.xml EX-101.PRE 272757
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 17839120
SIC: 2834 Pharmaceutical Preparations